Therapeutic glucocorticoid administration alters the diurnal pattern of dehydroepiandrosterone

Endocrine

Volumn 46, Issue 3, 2014, Pages 668-671

  Collomp, R ^a   Labsy, Z ^b   Zorgati, H ^b   Prieur, F ^b   Cottin, F ^b   Do, M C ^b   Gagey, O ^b   Lasne, F ^c   Collomp, K ^b,c,d  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b Universite Paris Sud   (France)

^c Agence Francaise de Lutte contre le Dopage   (France)

^d UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Circadian rhythm; DHEA; Healthy men; Prednisone; Saliva

Indexed keywords

GLUCOCORTICOID; PRASTERONE; PREDNISONE; PREDNISONE ACETATE; TESTOSTERONE;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SALIVA ANALYSIS; STEROID THERAPY; CHEMISTRY; DRUG EFFECTS; PHYSIOLOGY; SALIVA; YOUNG ADULT;

CIRCADIAN RHYTHM; DEHYDROEPIANDROSTERONE; GLUCOCORTICOIDS; HUMANS; MALE; SALIVA; TESTOSTERONE; YOUNG ADULT;

EID: 84904566896     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0122-9     Document Type: Article

References (24)

1. F. Hucklebridge, T. Hussain, P. Evans, A. Clow, The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology 30, 51-57 (2005)
2. A. Oskis, A. Clow, L. Thorn, C. Loveday, F. Hucklebridge, Differences between diurnal patterns of salivary cortisol and dehydroepiandrosterone in healthy female adolescents. Stress 15, 110-114 (2012)
3. W.J. Kraemer, C.C. Loebel, J.S. Volek, N.A. Ratamess, R.U. Newton, R.B. Wickham, L.A. Gotshalk, N.D. Duncan, S.A. Mazzetti, A.L. Gómez, M.R. Rubin, B.C. Nindl, K. Häkkinen, The effect of heavy resistance exercise on the circadian rhythm of salivary testosterone in men. Eur. J. Appl. Physiol. 84, 13-18 (2001)
4. Z. Labsy, F. Prieur, B. Le Panse, M.C. Do, O. Gagey, F. Lasne, K. Collomp, The diurnal patterns of cortisol and dehydroepiandrosterone in relation to intense aerobic exercise in recreationally trained soccer players. Stress 16, 261-265 (2013)
5. D.A. Granger, F.B. Schwartz, A. Booth, M. Curran, D. Zakaria, Assessing dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of children, adolescents and adults. Psychoneuroendocrinology 24, 567-579 (1999)
6. G. Lac, A. Robert, Salivary assays in saliva: a method to detect plasmatic contaminations. Arch. Int. Physiol. Biochim. Biophys. 101, 257-262 (1993)
7. R. Thomasson, A. Baillot, L. Jollin, A.M. Lecoq, V. Amiot, F. Lasne, K. Collomp, Correlation between plasma and saliva adrenocortical hormones in response to submaximal exercise. J. Physiol. Sci. 60, 435-439 (2010)
8. A. Baillot, N. Vibarel-Rebot, R. Thomasson, L. Jollin, V. Amiot, P. Emy, K. Collomp, Serum and saliva adrenocortical hormones in obese diabetic men during submaximal exercise. Horm. Metab. Res. 43, 148-150 (2011)
9. M.J. Carella, L.S. Srivastava, V.V. Gossain, D.R. Rovner, Hypothalamic-pituitaryadrenal function 1 week after a short burst of steroid therapy. J. Clin. Endocrinol. Metab. 76, 1188-1191 (1993)
10. R.J. Spiegel, R.A. Vigersky, A.I. Oliff, C.K. Echelberger, J. Bruton, D.G. Poplack, Adrenal suppression after short-term corticosteroid therapy. Lancet 24, 630-633 (1979)
11. T.B. Casale, H.S. Nelson, W.E. Stricker, H. Raff, K.B. Newman, Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann. Allergy Asthma Immunol. 87, 379-385 (2001)
12. J.A. Zora, D. Zimmerman, T.L. Carey, E.J. O'Connell, J.W. Yunginger, Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J. Allergy. Clin. Immunol. 77, 9-13 (1986)
13. A.C. Watson, R.L. Rosenfield, V.S. Fang, Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Clin. Endocrinol. 28, 471-475 (1988)
14. D. Brigell, V. Fang, R.L. Rosenfeld, Recovery of responses to ovine corticotrophin releasing hormone after withdrawal of a short course of glucocorticoid. J. Clin. Endocrinol. Metab. 74, 1036-1039 (1992)
15. L. Jollin, R. Thomasson, B. Le Panse, A. Baillot, N. Vibarel- Rebot, A.M. Lecoq, V. Amiot, J. De Ceaurriz, K. Collomp, Saliva DHEA and cortisol responses following short-term corticosteroid intake. Eur. J. Clin. Investig. 40, 183-186 (2010)
16. K. Collomp, A. Arlettaz, H. Portier, A.M. Lecoq, B. Le Panse, N. Rieth, J. De Ceaurriz, Short-term glucocorticoid intake combined with intense training on performance and hormonal responses. Br. J. Sports Med. 42, 983-988 (2008)
17. P. Marquet, G. Lac, A. Chassain, G. Habrioux, F. Galen, Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones. J. Appl. Physiol. 87, 183-188 (1999)
18. L. Parker, Control of adrenal androgen secretion. Endocrinol. Metab. Clin. North Am. 20, 401-421 (1991)
19. W. Arlt, H. Justl, F. Callies, M. Reincke, D. Hubler, M. Oettel, M. Ernst, H.M. Schulte, B. Allolio, Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J. Clin. Endocrinol. Metab. 83, 1928-1934 (1998)
20. F. Labrie, A. Bélanger, P. Bélanger, R. Bérubé, C. Martel, L. Cusan, J. Gomez, B. Candas, V. Chaussade, I. Castile, C. Deloche, J. Leclaire, Metabolism of DHEA in postmenopausal women following percutaneous administration. J. Steroid Biochem. Mol. Biol. 103, 178-188 (2007)
21. P.D. Kroboth, F.S. Salek, A.L. Pittenger, T.J. Fabian, R.F. Frye, DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39, 327-348 (1999)
22. A.M. Traish, H.P. Kang, F. Saad, A.T. Guay, Dehydroepian-drosterone (DHEA) - a precursor steroid or an active hormone in human physiology. J. Sex. Med. 8, 2960-2982 (2011)
23. E. Barrett-Connor, Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 117, 807-811 (1992)
24. M.C. Jimenez, Q. Sun, M. Schürks, S. Chiuve, F.B. Hu, J.E. Manson, K.M. Rexrode, Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke 44, 1784-1789 (2013)